SailPoint Soars on Q1 Results
SailPoint, Inc. (NASDAQ: SAIL) shares took off like a speedboat Wednesday. The Austin, Texas-based company, a leader in enterprise identity security, today announced financial results for its fiscal first quarter ended April 30, 2025.“We delivered another strong quarter, driven by continued expansion across our customer base and strong adoption among Fortune 500 and Forbes Global 2000 companies,” said CEO Mark McClain. Total Annual Recurring Revenue (ARR) was $925 million, an increase of 30% year-over-year. SaaS ARR was $574 million, an increase of 39% year-over-year.Total revenue was $230 million, an increase of 23% year-over-year. Subscription revenue was $215 million, an increase of 27% year-over-year.GAAP operating loss was $(185) million, or (80)% of revenue, compared to $(68) million, or (36)% of revenue in fiscal Q1 2025. Adjusted income from operations was $24 million, or 10% of revenue, compared to $19 million, or 10% of revenue in fiscal Q1 2025.Enterprises are turning to SailPoint to manage both human and digital identities at the scale and speed required to stay ahead. Our ability to deliver both breadth and depth of identity security—on a platform that’s AI and data-driven and built for extensibility—combined with disciplined execution, fuel our consistent performance.”“At SailPoint,” reads this morning’s news release, “we believe enterprise security must start with identity at the foundation. Today’s enterprise runs on a diverse workforce of not just human but also digital identities—and securing them all is critical.” SAIL shares jumped $3.44, or 17%, to $23.09.
Recent Posts

Romanian Inflation Ends Tumultuous Year in Politics Close to 10%

UK Boosts Support For Offshore Wind in Bumper Auction

Ireland Is Trying to Get Back on the Data Center Bandwagon

Notice Concerning Change of Representative Executive Officer

Polish Recycler Bets Millions on Europe’s Critical Metals Push

Blistering Metals Rally Sends Silver, Tin and Copper to Records

Wellington Management Appoints Alex Behm to Strengthen Secondaries Capabilities

TCS and AMD Announce Strategic Collaboration to Drive AI Adoption at Scale

New data reinforces Ipsen’s commitment to bringing solutions and addressing care gaps in neurological diseases at TOXINS

TOXINS 2026: Clinical Updates on Galderma’s Leading Neuromodulator Portfolio Further Reinforce Its Leadership in Injectable Aesthetics


